Ziarco Completes Series A

Ziarco, a clinical-stage biotechnology company, has completed a Series A financing. Biotechnology Value Fund L.P. and other affiliates of BVF Partners L.P. led the funding, with participation by Pfizer Venture Investments.

North AmericaUSBriefs